Nationwide cohort study demonstrates increased risk of interstitial lung diseases in inflammatory bowel disease patients, suggesting further monitoring is needed.
Key Points
Patients with inflammatory bowel disease had a 48% increased risk of interstitial lung diseases compared to general population comparators, highlighting a significant health concern.
The study identified 438 cases of interstitial lung diseases among 85,705 patients with inflammatory bowel disease over 14 years, indicating a concerning incidence.
Cox regression was used to analyze hazard ratios for interstitial lung diseases in a nationwide cohort study, revealing important epidemiological insights.
Findings show that patients with inflammatory bowel disease are at a significantly higher risk of developing interstitial lung diseases than their non-IBD siblings.